Igartua M - Search Results

1

Genetically engineered loaded extracellular vesicles for drug delivery.

Erana-Perez Z, Igartua M, Santos-Vizcaino E, Hernandez RM. Erana-Perez Z, et al. Among authors: igartua m. Trends Pharmacol Sci. 2024 Apr;45(4):350-365. doi: 10.1016/j.tips.2024.02.006. Epub 2024 Mar 19. Trends Pharmacol Sci. 2024. PMID: 38508958 Review.

2

Encapsulated cell technology: from research to market.

Orive G, Hernández RM, Gascón AR, Igartua M, Pedraz JL. Orive G, et al. Among authors: igartua m. Trends Biotechnol. 2002 Sep;20(9):382-7. doi: 10.1016/s0167-7799(02)02037-1. Trends Biotechnol. 2002. PMID: 12175769 Review.

3

Controversies over stem cell research.

Orive G, Hernández RM, Gascón AR, Igartua M, Pedraz JL. Orive G, et al. Among authors: igartua m. Trends Biotechnol. 2003 Mar;21(3):109-12. doi: 10.1016/S0167-7799(03)00003-9. Trends Biotechnol. 2003. PMID: 12628366

4

In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.

Ochoa L, Igartua M, Hernández RM, Solinís MA, Gascón AR, Pedraz JL. Ochoa L, et al. Among authors: igartua m. Eur J Pharm Biopharm. 2010 Jun;75(2):232-7. doi: 10.1016/j.ejpb.2010.02.008. Epub 2010 Feb 14. Eur J Pharm Biopharm. 2010. PMID: 20159037

5

Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides.

Mata E, Igartua M, Hernández RM, Rosas JE, Patarroyo ME, Pedraz JL. Mata E, et al. Among authors: igartua m. Drug Deliv. 2010 Sep-Oct;17(7):490-9. doi: 10.3109/10717544.2010.483254. Drug Deliv. 2010. PMID: 20500129

6

Design of a composite drug delivery system to prolong functionality of cell-based scaffolds.

Murua A, Herran E, Orive G, Igartua M, Blanco FJ, Pedraz JL, Hernández RM. Murua A, et al. Among authors: igartua m. Int J Pharm. 2011 Apr 4;407(1-2):142-50. doi: 10.1016/j.ijpharm.2010.11.022. Epub 2010 Nov 19. Int J Pharm. 2011. PMID: 21094235

7

Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.

Mata E, Igartua M, Patarroyo ME, Pedraz JL, Hernández RM. Mata E, et al. Among authors: igartua m. Eur J Pharm Sci. 2011 Sep 18;44(1-2):32-40. doi: 10.1016/j.ejps.2011.05.015. Epub 2011 Jun 15. Eur J Pharm Sci. 2011. PMID: 21699977

8

An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccines.

Salvador A, Igartua M, Hernández RM, Pedraz JL. Salvador A, et al. Among authors: igartua m. J Drug Deliv. 2011;2011:181646. doi: 10.1155/2011/181646. Epub 2011 Jun 15. J Drug Deliv. 2011. PMID: 21773041 Free PMC article.

9

Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines.

Salvador A, Igartua M, Hernández RM, Pedraz JL. Salvador A, et al. Among authors: igartua m. Vaccine. 2012 Jan 11;30(3):589-96. doi: 10.1016/j.vaccine.2011.11.057. Epub 2011 Nov 26. Vaccine. 2012. PMID: 22119926

10

Plasmodium falciparum malaria vaccines: current status, pitfalls and future directions.

Salvador A, Hernández RM, Pedraz JL, Igartua M. Salvador A, et al. Among authors: igartua m. Expert Rev Vaccines. 2012 Sep;11(9):1071-86. doi: 10.1586/erv.12.87. Expert Rev Vaccines. 2012. PMID: 23151165 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page